Tideglusib 5mg
Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy
| Trivial name | Tideglusib 5mg |
| Catalog Number | A11592-5 |
| Alternative Name(s) | 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione |
| Molecular Formula | C19H14N2O2S |
| CAS# | 865854-05-3 |
| SMILES | C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43 |
| Size | 5mg |
| Supplier Page | http://www.adooq.com/tideglusib.html |